Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis

NCT00241111 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

148

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer With Bone Metastasis

Interventions

DRUG: zoledronic acid

Sponsor

Novartis Pharmaceuticals